You can cancel at anytime
December 9, 2025 Update on MDL cases With the explosive growth in the use of Ozempic and other GLP-1based weight-loss drugs, its no surprise that the related class action MDL continues to expand
Here are some critical considerations: 1
Ozempic was approved for type 2 diabetes in 2017, but its origins at Novo Nordisk stretch back nearly a decade earlier
People with autoimmune disorders (especially thyroid disorders such as Hashimotos thyroiditis and Graves disease) Type 1 diabetes, vitiligo, lupus, Addisons disease, ulcerative colitis, infertility, acquired agammaglobulinemia, or a family history of these disorders
Easy & Convenient Perfect for busy lifestyles, this GLP-1 supplement weight loss shake is quick to preparejust mix with water or your favorite milk for a smooth, creamy drink that supports your weight loss journey while keeping you satisfied